Skip to main content
Clinical Trials/JPRN-UMIN000003051
JPRN-UMIN000003051Not yet recruiting未知

An exploratory study for clinical benefits of the guideline on drug use in subjects with pediatric obsessive compulsive disorder - An exploratory study for clinical benefits of the guideline on drug use in subjects with pediatric obsessive compulsive disorder

Department of Child Psychiatry, The University of Tokyo Hospital0 sites70 target enrollmentStarted: January 18, 2010Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
6years-old to 18years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Subjects with severe brain organic disease 2. Subjects with current DSM-IV-TR schizophrenia and other psychotic disorders or bipolar disorder 3. Subjects with mental retardation (IQ < 70) 4. Subjects who are administrated neurotropics except the test drugs from 7 days prior to the trial start 5. Subjects who are hospitalized 6. Subjects who are receiving structured cognitive behavioral therapy for OCD at the trial start 7. Subjects with current or past history of convulsion 8. Subjects with current or past history of serious suicidal ideation or attempt 9. Subjects with current or past history allergy for the test drugs 10. Pregnant or lactating women 11. Patient whom examination doctor judged improper as a trial subject

Investigators

Sponsor
Department of Child Psychiatry, The University of Tokyo Hospital

Similar Trials